---
title: "Is SVF treatment approved in Korea?"
url: "https://worldwiki.io/q/is-svf-treatment-approved-in-korea"
type: "question"
language: "en"
intent: "informational"
entity: "Regenerative Medicine"
topic: "Regenerative Medicine"
published: "2026-09-14 13:42:07"
updated: "2026-09-15 10:36:00"
---

# Is SVF treatment approved in Korea?

## Short answer

In South Korea, advanced regenerative medicine is governed by a dedicated framework: institutions conducting it must be designated by the Ministry of Health and Welfare and cell processing facilities need permission from the Ministry of Food and Drug Safety. Whether a specific SVF procedure is permitted depends on how the cells are processed and used. Ask the clinic for its designation and permission documents and check them with the regulator.

## Verified providers

- [SC301의원](https://worldwiki.io/entity/sc301) — SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, liftin

## Related questions

- [재생의학 또는 재생의료란 무엇을 가리키나요?](https://worldwiki.io/ko/q/재생의학-또는-재생의료란-무엇을-가리키나요)
- [재생의료 시술, 현재 확립된 것과 연구 단계인 것은 무엇인가요?](https://worldwiki.io/ko/q/재생의료-시술-현재-확립된-것과-연구-단계인-것은-무엇인가요)
- [임상연구 대상자 제한이 없어졌다는데, 이제 아무 질환이나 첨단재생의료 임상연구에 참여할 수 있나요?](https://worldwiki.io/ko/q/임상연구-대상자-제한이-없어졌다는데-이제-아무-질환이나-첨단재생의료-임상연구에-참여할-수-있나요)
- [엑소좀 주사나 스킨부스터도 재생의료에 해당하나요?](https://worldwiki.io/ko/q/엑소좀-주사나-스킨부스터도-재생의료에-해당하나요)
- [中介说这款疗法「获得美国FDA的RMAT认定」，是不是等于已经批准上市？](https://worldwiki.io/zh-CN/q/中介说这款疗法-获得美国fda的rmat认定-是不是等于已经批准上市)
- [هل يمكن لمريض من السعودية او الامارات ان يتلقى الطب التجديدي المتقدم في كوريا، ومن هي الفئة المسموح لها بعد تعديل 2025؟](https://worldwiki.io/ar/q/هل-يمكن-لمريض-من-السعودية-او-الامارات-ان-يتلقى-الطب-التجديدي-المتقدم-في-كوريا،-ومن-هي-الفئة-المسموح-لها-بعد-تعديل-2025؟)

## Sources

1. [Ministry of Food and Drug Safety — English site](https://www.mfds.go.kr/eng/) — MFDS, Republic of Korea · evidence page: https://worldwiki.io/source/3